Redcare Pharmacy (RDC) Price & Analysis

Compare

68 Followers

RDC Stock Chart & Stats

€40.14

€4.70(3.90%)

At close: Jan 09 4:00 PM EST

€40.14

€4.70(3.90%)

Day’s Range― - ―

52-Week Range€39.40 - €140.80

Previous CloseN/A

Volume73.26K

Average Volume (3M)132.76K

Market Cap

€826.02M

Enterprise Value€1.14B

Total Cash (Recent Filing)€203.50M

Total Debt (Recent Filing)€415.60M

Price to Earnings (P/E)―

Beta1.26

Next Earnings

May 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.44

Shares Outstanding20,578,390

10 Day Avg. Volume128,637

30 Day Avg. Volume132,758

Financial Highlights & Ratios

PEG Ratio1.97

Price to Book (P/B)2.85

Price to Sales (P/S)0.45

P/FCF Ratio-23.25

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€106.50

Price Target Upside165.32% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering7

EPS Forecast (FY)0.08

Revenue Forecast (FY)€3.40B

Bulls Say, Bears Say

Bulls Say

German Prescription Medicines GrowthStrong acceleration in the German prescription medicines business enabled the company to meet its sales target, signaling durable demand and improved market traction in a core market.

Overall Sales MomentumRobust overall sales growth supports the case for a valuation reassessment, as sustained top-line improvement can justify a higher market multiple.

Sales Resilience Under Market PressureAchievement of sales objectives despite major market concerns indicates revenue resilience that could attract investor reassessment if macro sentiment stabilizes.

Bears Say

Conservative Management TargetsManagement's medium-term revenue and margin targets sit below market expectations, which may limit upside and raise questions about growth visibility.

Non-prescription Segment WeaknessThe non-prescription segment underperformed even with supportive seasonal demand, highlighting vulnerabilities in consumer-facing revenue streams.

Profitability PressureProfitability metrics weakened as margins moved toward the lower end of guidance, suggesting growth was achieved at the expense of operating profitability.

Redcare Pharmacy News

Buy Rating Maintained as Strong Prescription Growth and Long-Term Margin Ambition Outweigh Near-Term Profitability Pressure

Redcare Pharmacy, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Martin Comtesse from...

12d ago

0RJT Upcoming Earnings Report: What to Expect?

Redcare Pharmacy (0RJT) is scheduled to report 4th quarter earnings on 03/04/2026. Regarding Q4 estimates, Wall Street analysts...

14d ago

Positive Financial Performance and Growth Prospects Justify Buy Rating for Redcare Pharmacy

Jefferies analyst Martin Comtesse maintained a Buy rating on Redcare Pharmacy today and set a price target of...

5M ago

Redcare Pharmacy’s Rebound: Analyst Recommends Buy Amidst Sales Recovery and Strong Future Outlook

Martin Comtesse, an analyst from Jefferies, maintained the Buy rating on Redcare Pharmacy. The associated price target remains...

5M ago

Optimistic Buy Rating for Redcare Pharmacy Driven by Market Expansion and Strategic Digital Transformation

Redcare Pharmacy, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Martin Comtesse from...

6M ago

Redcare Pharmacy: Strong Financial Performance and Positive Outlook Justify Buy Rating

Jefferies analyst Martin Comtesse maintained a Buy rating on Redcare Pharmacy today and set a price target of...

8M ago

0RJT Earnings this Week: How Will it Perform?

Redcare Pharmacy (0RJT) is scheduled to report 2nd quarter earnings on 07/29/2025. Regarding Q2 estimates, Wall Street analysts...

8M ago

Redcare Pharmacy: Stable Performance and Growth Potential Amidst Temporary Challenges

Analyst Martin Comtesse from Jefferies maintained a Buy rating on Redcare Pharmacy and keeping the price target at...

9M ago

0RJT Upcoming Earnings Report: What to Expect?

Redcare Pharmacy (0RJT) is scheduled to report 1st quarter earnings on 05/06/2025. Regarding Q1 estimates, Wall Street analysts...

11M ago

Strong Customer Growth and Margin Improvement Justify Buy Rating for Redcare Pharmacy

Stifel Nicolaus analyst Yannik Siering maintained a Buy rating on Redcare Pharmacy (0RJT – Research Report) today and...

12M ago

RDC FAQ

What was Redcare Pharmacy’s price range in the past 12 months?

Redcare Pharmacy lowest stock price was €39.40 and its highest was €140.80 in the past 12 months.

What is Redcare Pharmacy’s market cap?

Redcare Pharmacy’s market cap is €826.02M.

When is Redcare Pharmacy’s upcoming earnings report date?

Redcare Pharmacy’s upcoming earnings report date is May 06, 2026 which is in 51 days.

How were Redcare Pharmacy’s earnings last quarter?

Redcare Pharmacy released its earnings results on Mar 04, 2026. The company reported -€1.44 earnings per share for the quarter, missing the consensus estimate of -€0.504 by -€0.936.

Is Redcare Pharmacy overvalued?

According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Redcare Pharmacy pay dividends?

Redcare Pharmacy does not currently pay dividends.

What is Redcare Pharmacy’s EPS estimate?

Redcare Pharmacy’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Redcare Pharmacy have?

Redcare Pharmacy has 20,578,390 shares outstanding.

What happened to Redcare Pharmacy’s price movement after its last earnings report?

Redcare Pharmacy reported an EPS of -€1.44 in its last earnings report, missing expectations of -€0.504. Following the earnings report the stock price went down -21.008%.

Which hedge fund is a major shareholder of Redcare Pharmacy?

Currently, no hedge funds are holding shares in DE:RDC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Redcare Pharmacy Stock Smart Score

Neutral

Analyst Consensus

Strong Buy

Average Price Target:
€106.50 (165.32% Upside)

Technicals

Fundamentals

Return on Equity

-7.76%

Trailing 12-Months

Asset Growth

21.28%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Redcare Pharmacy

Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.

Redcare Pharmacy (RDC) Earnings & Revenues

Historic Earnings Reports

RDC Stock 12 Month Forecast

Average Price Target

€106.50

▲(165.32% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"58":"€58","151":"€151","81.25":"€81.3","104.5":"€104.5","127.75":"€127.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€150.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":106.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€106.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":74,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€74.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[58,81.25,104.5,127.75,151],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.4,66.36923076923077,73.33846153846153,80.3076923076923,87.27692307692307,94.24615384615385,101.21538461538461,108.18461538461537,115.15384615384615,122.12307692307692,129.09230769230768,136.06153846153845,143.0307692307692,{"y":150,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.4,63.02307692307692,66.64615384615385,70.26923076923077,73.8923076923077,77.51538461538462,81.13846153846154,84.76153846153846,88.38461538461539,92.00769230769231,95.63076923076923,99.25384615384615,102.87692307692308,{"y":106.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.4,60.52307692307692,61.646153846153844,62.76923076923077,63.89230769230769,65.01538461538462,66.13846153846154,67.26153846153846,68.38461538461539,69.50769230769231,70.63076923076923,71.75384615384615,72.87692307692308,{"y":74,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":116.9,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.25,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.05,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.35,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >